M.D.C. Holdings, Inc. Financials

Market Capitalization $3.99 Billion as of Jan. 1, 2024

Valuations Metrics as of Jan. 25, 2025

Trailing PE	21.78
Forward PE	0.16
Price to Sales TTM	£1.09
Price to Book MRQ	£104.24
Enterprise to Revenue	1.85
Enterprise to EBITDA	14.77

Financial Reports as of Sep. 30, 2022

Financials

Fiscal Year Ends	2022-03-31
Most Recent Quarter	2022-09-30
Profit Margin	5.00%
Operating Margin	8.10%
Return on Assets TTM	2.30%
Return on Equity TTM	5.50%

Income Statement

Revenue TTM	£3,383,000,064
Revenue per Share TTM	£4.59
Quarterly Revenue Growth	9.50%
Gross Profit TTM	£706,000,000
EBITDA	£515,000,000
Net Income to Common TTM	£169,000,000
Diluted EPS TTM	£0.23
Quarterly Earnings Growth YoY	27.70%

Balance Sheet

Total Cash MRQ	£454,000,000
Total Cash per Share MRQ	£0.62
Total Debt MRQ	£
Total Debt to Equity MRQ	78.38
Current Ratio MRQ	1.49
Book Value per Share MRQ	£4.81

Cash Flow

Operating Cash Flow TTM	£470,000,000
Levered Free Cash Flow TTM	£183,750,000

MDC Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	737,244,032
Float Shares	340,672,992
Avg 10 Volume	5,327,159
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	48.87%
% Held by Institutions	39.20%

Stock Price Summary

Beta	0.42
Fifty Two Week Low	£0.00
Fifty Two Week High	£514.00
Fifty Two Week Change	17.76%
Day 50 MA	£498.38
Day 200 MA	£496.76

Dividends and Splits

Forward Annual Dividend Rate	£12.00
Forward Annual Dividend Yield	2.40%
Trailing Annual Dividend Rate	£3.00
Trailing Annual Dividend Yield	0.60%
Payout Ratio	13.04%
Dividend Date
Ex Dividend Date	2022-08-04
Last Split Factor
Last Split Date